Geode Capital Management
YARW

Geode Capital Management’s Yarrow Bioscience YARW Stock Holding History

Geode Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Sell
5,164
-1,290
-20% -$41.8K ﹤0.01% 3972
2026
Q1 		$193K Buy
6,454
+1,951
+43% +$56.9K ﹤0.01% 3929
2025
Q4 		$131K Buy
4,503
+1,761
+64% +$35.3K ﹤0.01% 4033
2025
Q3 		$45.9K Buy
2,742
+75
+3% +$2.45K ﹤0.01% 4309
2025
Q2 		$220K Sell
2,667
-3
-0.1% -$195 ﹤0.01% 3844
2025
Q1 		$211K Sell
2,670
-30
-1% -$3.69K ﹤0.01% 3834
2024
Q4 		$452K Buy
2,700
+8
+0.3% +$1.05K ﹤0.01% 3630
2024
Q3 		$253K Sell
2,692
-21
-0.8% -$1.99K ﹤0.01% 3828
2024
Q2 		$267K Buy
2,713
+577
+27% +$71.9K ﹤0.01% 3809
2024
Q1 		$328K Buy
2,136
+249
+13% +$26.8K ﹤0.01% 3768
2023
Q4 		$220K Buy
1,887
+1,336
+242% +$208K ﹤0.01% 3907
2023
Q3 		$110K Buy
551
+52
+10% +$11.3K ﹤0.01% 4217
2023
Q2 		$101K Hold
499
– – ﹤0.01% 4329
2023
Q1 		$76.8K Hold
499
– – ﹤0.01% 4423
2022
Q4 		$67K Sell
499
-1
-0.2% -$200 ﹤0.01% 4515
2022
Q3 		$100K Hold
500
– – ﹤0.01% 4579
2022
Q2 		$175K Sell
500
-23
-4% -$9.65K ﹤0.01% 4352
2022
Q1 		$305K Hold
523
– – ﹤0.01% 4173
2021
Q4 		$479K Hold
523
– – ﹤0.01% 4070
2021
Q3 		$653K Buy
523
+5
+1% +$9.7K ﹤0.01% 3902
2021
Q2 		$1.64M Sell
518
-293
-36% -$1.16M ﹤0.01% 3356
2021
Q1 		$4.99M Buy
811
+170
+27% +$1.23M ﹤0.01% 2789
2020
Q4 		$3.65M Buy
641
+36
+6% +$226K ﹤0.01% 2763
2020
Q3 		$3.61M Buy
605
+102
+20% +$595K ﹤0.01% 2576
2020
Q2 		$3.13M Buy
503
+372
+284% +$2.52M ﹤0.01% 2594
2020
Q1 		$1.27M Buy
131
+95
+264% +$1.49M ﹤0.01% 2912
2019
Q4 		$602K Buy
36
+2
+6% +$33.3K ﹤0.01% 3445
2019
Q3 		$555K Hold
34
– – ﹤0.01% 3439
2019
Q2 		$740K Buy
34
+9
+36% +$223K ﹤0.01% 3327
2019
Q1 		$700K Buy
25
+2
+9% +$48K ﹤0.01% 3302
2018
Q4 		$347K Buy
23
+1
+5% +$22.4K ﹤0.01% 3497
2018
Q3 		$795K Buy
22
+3
+16% +$92.6K ﹤0.01% 3310
2018
Q2 		$558K Buy
19
+1
+6% +$38.9K ﹤0.01% 3397
2018
Q1 		$2.44M Buy
+18
New +$2.19M ﹤0.01% 2656

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management's YARW Position: Q2 2026 in Review

Geode Capital Management reduced its Yarrow Bioscience (YARW) stake by 20% in Q2 2026, selling an estimated $41.8K and leaving 5,164 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #3972.

Geode Capital Management first reported a position in YARW in Q1 2018 and has held it in 34 quarters since. The position peaked at $4.99M in Q1 2021. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Geode Capital Management held 5,164 shares of Yarrow Bioscience worth $168K as of Q2 2026.
  • Geode Capital Management sold 1,290 Yarrow Bioscience shares in Q2 2026, an estimated $41.8K.
  • Yarrow Bioscience made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3972 holding.
  • Geode Capital Management first reported a position in Yarrow Bioscience in Q1 2018 and has held it in 34 quarters since.
  • Geode Capital Management's Yarrow Bioscience position peaked at $4.99M in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.